CARB-X Funds Development of POC Home Test for Gonorrhea and Chlamydia
Scout received funding to develop a test to detect and differentiate between Neisseria gonorrhoeae and Chlamydia trachomatis quickly.
Read MorePosted by Andy Lundin | Apr 18, 2024 | Sexually Transmitted Diseases |
Scout received funding to develop a test to detect and differentiate between Neisseria gonorrhoeae and Chlamydia trachomatis quickly.
Read MorePosted by Andy Lundin | Nov 16, 2023 | Sexually Transmitted Diseases |
The FDA granted marketing authorization to a diagnostic test for chlamydia and gonorrhea with at-home sample collection.
Read MorePosted by Andy Lundin | Sep 29, 2022 | Sexually Transmitted Diseases |
Study revealed Lucira’s testing assays offer a 98% accuracy rate in detecting the two sexually transmitted infections.
Read MorePosted by Melanie Hamilton-Basich | Apr 2, 2021 | POC Instruments |
CLIA waiver clearance allows Binx to facilitate single visit testing for CT/NG in any of the more than 220,000 locations across the Unites States holding a CLIA certificate of waiver.
Read MorePosted by Chaunie Brusie | Jul 12, 2019 | Fertility Testing, Sexually Transmitted Diseases, Womens Health |
The Aptima Combo 2 and Xpert CT/NG are the first assays cleared to perform extragenital diagnostic testing for chlamydia and gonorrhea via specimens from the throat and rectum.
Read More